Cargando…

Mesenchymal Stromal Cell Characteristics and Regenerative Potential in Cardiovascular Disease: Implications for Cellular Therapy

Administration of mesenchymal stromal cells (MSCs) is a promising strategy to treat cardiovascular disease (CVD). As progenitor cells may be negatively affected by both age and comorbidity, characterization of MSC function is important to guide decisions regarding use of allogeneic or autologous cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Rhijn-Brouwer, F. C. C., Gremmels, H., Fledderus, J. O., Verhaar, M. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047272/ https://www.ncbi.nlm.nih.gov/pubmed/29895169 http://dx.doi.org/10.1177/0963689717738257

Ejemplares similares

Cellular Therapies in Systemic Sclerosis: Recent Progress
por: van Rhijn-Brouwer, Femke C. C., et al.
Publicado: (2016)

Mesenchymal stromal cells for the treatment of critical limb ischemia: context and perspective
por: Gremmels, Hendrik, et al.
Publicado: (2013)

Exhaustion of the bone marrow progenitor cell reserve is associated with major events in severe limb ischemia
por: Gremmels, Hendrik, et al.
Publicado: (2019)

A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol
por: van Rhijn-Brouwer, Femke C C, et al.
Publicado: (2018)

Evaluation of bone marrow-derived cell-based therapies in the hindlimb ischaemia model: a protocol for a systematic review and meta-analysis
por: van Rhijn-Brouwer, Femke Christina Ching Chuan, et al.
Publicado: (2021)

Human Bone Marrow Mononuclear Cells Do Not Improve Limb Perfusion in the Hindlimb Ischemia Model
por: van Rhijn-Brouwer, Femke Christina Ching-Chuan, et al.
Publicado: (2022)

Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy
por: Maldonado, Vitali V., et al.
Publicado: (2023)

Paracrine Proangiogenic Function of Human Bone Marrow-Derived Mesenchymal Stem Cells Is Not Affected by Chronic Kidney Disease
por: van Rhijn-Brouwer, Femke C. C., et al.
Publicado: (2019)

Dental mesenchymal stromal/stem cells in different microenvironments— implications in regenerative therapy
por: Okić-Đorđević, Ivana, et al.
Publicado: (2021)

Molecular Profiles of Cell-to-Cell Variation in the Regenerative Potential of Mesenchymal Stromal Cells
por: O'Connor, Kim C.
Publicado: (2019)

The Transcription Factor Nrf2 Protects Angiogenic Capacity of Endothelial Colony-Forming Cells in High-Oxygen Radical Stress Conditions
por: Gremmels, Hendrik, et al.
Publicado: (2017)

Editorial: Mesenchymal Stromal Cell Therapy for Regenerative Medicine
por: Capilla-González, Vivian, et al.
Publicado: (2022)

Potential Application of Cord Blood-Derived Stromal Cells in Cellular Therapy and Regenerative Medicine
por: Kluth, Simone Maria, et al.
Publicado: (2012)

Regenerative Potential of Mesenchymal Stromal Cells: Age-Related Changes
por: Bruna, Flavia, et al.
Publicado: (2016)

Reparative and Regenerative Effects of Mesenchymal Stromal Cells—Promising Potential for Kidney Transplantation?
por: Pool, Merel, et al.
Publicado: (2019)

Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies
por: Baldari, Silvia, et al.
Publicado: (2017)

Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases
por: Che, Zhengping, et al.
Publicado: (2022)

Regenerative and Transplantation Medicine: Cellular Therapy Using Adipose Tissue-Derived Mesenchymal Stromal Cells for Type 1 Diabetes Mellitus
por: Takahashi, Hiroyuki, et al.
Publicado: (2019)

The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings
por: Merimi, Makram, et al.
Publicado: (2021)

Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine
por: Papait, Andrea, et al.
Publicado: (2020)

Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease
por: van Koppen, Arianne, et al.
Publicado: (2015)

Human umbilical cord mesenchymal stromal cells in regenerative medicine
por: Detamore, Michael S
Publicado: (2013)

Mesenchymal stromal cells: main factor or helper in regenerative medicine?
por: Zander, Axel R, et al.
Publicado: (2011)

Collagen scaffold enhances the regenerative properties of mesenchymal stromal cells
por: Rashedi, Iran, et al.
Publicado: (2017)

Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering
por: Fitzsimmons, Ross E. B., et al.
Publicado: (2018)

The application of resveratrol to mesenchymal stromal cell-based regenerative medicine
por: Hu, Chenxia, et al.
Publicado: (2019)

Extracellular Vesicles: Potential Roles in Regenerative Medicine
por: De Jong, Olivier G., et al.
Publicado: (2014)

The Ethical Implications of Tissue Engineering for Regenerative Purposes: A Systematic Review
por: de Kanter, Anne-Floor J., et al.
Publicado: (2023)

Regenerative potential of mesenchymal stromal cells in wound healing: unveiling the influence of normoxic and hypoxic environments
por: Mahjoor, Mohamad, et al.
Publicado: (2023)

Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy
por: Sagar, Rachel, et al.
Publicado: (2018)

Renal Regenerative Potential of Extracellular Vesicles Derived from miRNA-Engineered Mesenchymal Stromal Cells
por: Tapparo, Marta, et al.
Publicado: (2019)

Constitutive aryl hydrocarbon receptor facilitates the regenerative potential of mouse bone marrow mesenchymal stromal cells
por: Huang, Jing, et al.
Publicado: (2023)

Cell Therapy for Chronic Limb‐Threatening Ischemia: Current Evidence and Future Directions
por: Teraa, Martin, et al.
Publicado: (2018)

Regenerative Cardiovascular Therapies: Stem Cells and Beyond
por: Wernly, Bernhard, et al.
Publicado: (2019)

Pro-regenerative Dialogue Between Macrophages and Mesenchymal Stem/Stromal Cells in Osteoarthritis
por: Bohaud, Candice, et al.
Publicado: (2021)

Aging of mesenchymal stem cells: Implication in regenerative medicine
por: Yang, Yueh-Hsun Kevin
Publicado: (2018)

Renal Regenerative Potential of Different Extracellular Vesicle Populations Derived from Bone Marrow Mesenchymal Stromal Cells
por: Bruno, Stefania, et al.
Publicado: (2017)

Cellular expansion of MSCs: Shifting the regenerative potential
por: Miclau, Katherine, et al.
Publicado: (2022)

Impact of Aging on the Regenerative Properties of Bone Marrow-, Muscle-, and Adipose-Derived Mesenchymal Stem/Stromal Cells
por: Beane, Olivia S., et al.
Publicado: (2014)

Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine
por: Miceli, Vitale, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_llcvp39mvn0s2f5kadmajpcj6n